April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Further Development of an in vitro Model of Human Corneal Fibrosis
Author Affiliations & Notes
  • X. Q. Guo
    Schepens Eye Research Institute, Boston, Massachusetts
    Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
  • A. E. K. Hutcheon
    Schepens Eye Research Institute, Boston, Massachusetts
    Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
  • D. Karamichos
    Schepens Eye Research Institute, Boston, Massachusetts
    Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
  • J. D. Zieske
    Schepens Eye Research Institute, Boston, Massachusetts
    Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  X.Q. Guo, None; A.E.K. Hutcheon, None; D. Karamichos, None; J.D. Zieske, None.
  • Footnotes
    Support  NIH Grant R21EY018939
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 4533. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      X. Q. Guo, A. E. K. Hutcheon, D. Karamichos, J. D. Zieske; Further Development of an in vitro Model of Human Corneal Fibrosis. Invest. Ophthalmol. Vis. Sci. 2009;50(13):4533.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : We have demonstrated that a Vitamin C derivative (VitC) can stimulate human corneal fibroblasts to secrete and assemble matrix in a manner mimicking corneal development. We postulate that addition of transforming growth factor-β (TGF-β) would generate a model of corneal scarring.

Methods: : Human corneal fibroblasts were grown in four media conditions for 4 or 8 wks: (Group 1 or G1) Vit C only; (G2) Vit C for 4 wks, then VitC + TGF-β1 for 4 wks; (G3) VitC + TGF-β1 for 1 wk, then VitC only for 3 or 7 wks; and (G4) VitC + TGF-β1 for the entire time. Cultures were analyzed with TEM and indirect-immunofluorescence. Cellular fibronectin (cFN), -smooth muscle actin (SMA) and collagen type III (type III) were localized.

Results: : The thickness of the constructs increased with the addition of TGF-β1. Compared to G1, G2 increased 1.7-fold, G3 1.8/2.0-fold and G4 2.1/3.1-fold at 4 and 8 wks. In all TGF-β treated cultures, the cells became very long and flat, numerous cells with filaments were seen, the collagen levels increased, and long collagen fibrils could be seen. (4 wks) cFN is present in G1 at very low levels, whereas, in G4, cFN is present at high levels and G3 appears to be intermediate. Type III is present at very low levels in G1 and G3 in the lower half of the construct. However, in G4, Type III is found in the upper 1/5 of the construct. SMA positive cells are present throughout G3 and G4, while G1 only has a few positive cells at the bottom of the construct. (8 wks) Type III is found in the middle of the construct in G1, in the top half at high levels in G2 and G4, and in the middle of the construct in G3. SMA is present at low amounts in G1, throughout the construct at low levels in G3, and in numerous cells in G2 and G4. cFN in G1 and G3 is found at low levels in the top and bottom of the construct; whereas, G2 and 4 have cFN in high amounts at the top of the construct.

Conclusions: : The presence of TGF-β in the cultures for even one week resulted in elevated levels of matrix, cFN and myofibroblasts. Interesting, TGF-β stimulated the generation of aligned matrix, and fewer lamellae then control cultures.

Keywords: cornea: stroma and keratocytes • growth factors/growth factor receptors • extracellular matrix 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×